INTELLIGENT WATER SUPPLY CPU AND WATER TAP
    2.
    发明申请
    INTELLIGENT WATER SUPPLY CPU AND WATER TAP 审中-公开
    智能水供应CPU和水口

    公开(公告)号:US20110308641A1

    公开(公告)日:2011-12-22

    申请号:US12673193

    申请日:2009-05-05

    IPC分类号: F16K17/38

    摘要: An electronic intelligent touch control water faucet and an intelligent water supply central processor which includes a main body, an upper cover, an electromagnetic valve group, a temperature control and flow control member, a PCB control panel and an operation panel. The main body includes receiving troughs, two water inlet tubes and a water outlet tube communicated through pipes. The temperature control member includes a temperature control valve, a synchronous motor, and a temperature sensor. The temperature control valve communicates with the water inlet tubes and is driven and adjusted by the synchronous motor. PCB control panel controls the synchronous motor. The temperature sensor communicates the outlet water temperature to the PCB control panel. The flow control member includes a flow valve and a motor. The PCB control panel controls the motor driving the flow valve. The flow valve water outlet is connected to the water outlet tube.

    摘要翻译: 一种电子智能触摸控制水龙头和智能供水中央处理器,包括主体,上盖,电磁阀组,温度控制和流量控制构件,PCB控制面板和操作面板。 主体包括接收槽,两个进水管和通过管道连通的出水管。 温度控制构件包括温度控制阀,同步电动机和温度传感器。 温度控制阀与进水管连通,由同步电机驱动和调节。 PCB控制面板控制同步电机。 温度传感器将出口水温传达到PCB控制面板。 流量控制构件包括流量阀和马达。 PCB控制面板控制电机驱动流量阀。 流量阀出水口连接到出水管。

    13,13a-Dihydroberberine Derivatives For Use In Pharmaceutical Compositions
    3.
    发明申请
    13,13a-Dihydroberberine Derivatives For Use In Pharmaceutical Compositions 审中-公开
    13,13a-Dihydroberberine衍生物用于药物组合物

    公开(公告)号:US20100113494A1

    公开(公告)日:2010-05-06

    申请号:US12443401

    申请日:2007-09-30

    IPC分类号: A61K31/4375

    CPC分类号: C07D455/03

    摘要: The present invention provides 13,13a-dihydroberberine derivatives or their physiologically acceptable salts represented by the following formula, pharmaceutical compositions comprising the same, and uses thereof. The 13,13a-dihydroberberine derivatives have an activity of promoting glucose absorption in muscle cells, and the whole animal tests show that the present compounds have effects on improving glucose-tolerance and insulin-resistance, facilitating weight loss, relieving fatty liver and the like. Thus, the present compounds can be used in treating diabetes mellitus, adiposity, fatty liver and complications thereof induced by insulin resistance.

    摘要翻译: 本发明提供由下式表示的13,13a-二氢小檗碱衍生物或其生理学上可接受的盐,其包含其的药物组合物及其用途。 13,13a-二氢小檗碱衍生物具有促进肌肉细胞中葡萄糖吸收的活性,整个动物实验表明,本发明化合物具有改善葡萄糖耐量和胰岛素抵抗,促进体重减轻,减轻脂肪肝等作用 。 因此,本发明化合物可用于治疗由胰岛素抵抗引起的糖尿病,肥胖,脂肪肝及其并发症。